Diphtheria: are we ready for it?
EDITOR,-The article by Begg and Balraj discusses the adequacy of current control and containment measures for diphtheria.' We agree with the authors that the diagnosis of Corynebacterium diphtheriae and Corynebacterium ulcerans has in the past often been delayed or missed altogether as many laboratories have ceased to culture throat swabs routinely for these organisms.
The Public Health Laboratory Service (PHLS) Standardisation of Clinical Bacteriology Methods Working Group recommends in their standard operating procedure (SOP) on the investigation of throat swabs that all throat swabs should be cultured routinely for C diphtheriae and C ulcerans using Hoyle's tellurite medium.2
Reasons for this include: * Immunisation does not prevent asymptomatic carriage of the organism * Vaccinated individuals may still be susceptible * There is a risk of indigenous transmission * A major outbreak is possible * Early recognition of a case allows for containment of the patient * Treatment must be initiated at an early stage to reduce the risk of fatality. With laboratories returning to this kind of routine screening, isolation of C diphtheriae and C ukerans from asymptomatic carriers will be increased thereby minimising the potential for missed or delayed diagnosis. It will also allow for the collection of consistent epidemiological data on the presence of the organism in the population.
The PHLS has recently issued a standard method for the investigation of throat swabs as part of the 50 specimen SOPs to be issued to the PHLS during the next 18 months.3 These SOPs may also prove useful to microbiology laboratories other than the PHLS. KURT Prompt diagnosis and treatment of group A streptococcal infection has become increasingly important as there has been a worldwide resurgence in invasive group A streptococcal disease since the mid-1980s with the emergence of strains of increased virulence.5
Recently, it has been proposed that the underlying biochemical basis for the possible link between the use of NSAIDs and invasive group A streptococcal infection is the ability of NSAIDs to inhibit neutrophil function and enhance cytokine (particularly tumour necrosis factor) production.6 In addition, by masking cardinal signs of inflammation, such as myalgia, arthralgia, erythema and localised swelling, these agents may delay the recognition of invasive group A streptococcal infection until signs of shock and multiorgan failure are apparent. This hypothesis may also apply to staphylococcal toxic shock syndrome.
Varicella is an important predisposing factor for both invasive group A streptococcal and staphylococcal infection in immunocompetent children.7 NSAIDs may be particularly dangerous in this condition: their use has been associated with the progression to necrotising fasciitis and toxic shock syndrome.4
Antipyretics play an important part in the management of febrile young children with non-specific signs in whom the diagnosis is unclear. However, the possibility that NSAIDs may facilitate the invasion of group A streptococci should limit the use of these agents in patients with varicella or in those in whom the cause of fever is not known. Updating Common Symptoms of Disease in Children by R S Illingworth, this book follows a symptomatic as opposed to a system approach. For each of the 185 symptom (sign) headings a list of causes is followed by a text, giving a brief account of the conditions listed.
In an attempt to be thorough, many of the lists are lengthy and daunting not only to the medical student but also to the experienced paediatrician. Some attempt has been made to subdivide the causes but further subdivision would have supported the problem solv-
